Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Coral Laboratories Ltd has informed BSE that a Board meeting is scheduled for May 30, 2026. The meeting will consider and approve the standalone audited financial results for Q4 and FY ended March 31, 2026. Additionally, the Board will discuss recommendation of final dividend for FY 2025-26. The meeting also includes appointments of Internal Auditor and Cost Auditor for FY 2026-27. Trading window for dealing in equity shares has been closed since April 1, 2026, and will remain closed for 48 hours after the financial results are declared.
This is a routine regulatory intimation ahead of the FY2026 results announcement. The dividend discussion and auditor appointments are standard agenda items. Actual financial details and their impact on the stock will be known only after the results are declared on May 30, 2026.